8:00 – 8:15 am

ACADEMIA/INDUSTRY/FDA/NIH ROUNDTABLE ON ENGINEERING THE FUTURE OF NEUROINTERVENTIONAL CARE-OBJECTIVES

Location: Metropolitan Ballroom

Chairs:

Ajay K. Wakhloo, Tufts University School of Medicine, Boston, MA

Ricardo Hanel, Baptist Health, Jacksonville, FL

Raul G. Nogueira, University of Pittsburgh School of Medicine, Pittsburgh, PA

Introduction: Ajay K. Wakhloo, Tufts University School of Medicine, Boston, MA
Marc Fisher, Beth Israel Diaconess, Harvard Medical School, Boston, MA

8:15 – 9:15 am

SESSION 1: WHAT HAS ARISEN – TRANSLATING INNOVATION INTO INTERVENTION; UPDATES ON ANEURYSM, ICH, MMA, AND VENOUS INNOVATIONS

Location: Metropolitan Ballroom

Chair: Jared Knopman, Weill Cornell Medicine, NY

8:15 – 8:20
cSDH and MIDDLE MENINGEAL ARTERY EMBOLIZATION
Presentation by Peter Kan, UTMB, Galveston, TX

8:20 – 8:25
CEREBRAL VENOUS DISEASE
Presentation by Matthew Amans, UCSF, CA

8:25 – 8:30
bAVM
Presentation by Edgar Samaniego, University of Iowa, Iowa City, IA

 8:30 – 8:35
ICH
Presentation by Mark Bain, Cleveland Clinic, Cleveland, OH

8:35 – 8:45
REACH and MINUTE trial comparison
Presentation by Magdy Selim, Harvard Medical School, Boston, MA & Chris Kellner, Mount Sinai Health System, New York, NY

8:45 – 9:15
ROUNDTABLE PANEL DISCUSSION

Panelists:
Jaime Raben, Director, Division of Neurosurgical, Neurointerventional, and Neurodiagnostic Devices, FDA
Sara Thompson, Assistant Director, Neurointerventional Devices Team, FDA
Clemens Schirmer, Geisinger Commonwealth School of Medicine, Scranton, PA
Luis Savastano, University of California, San Francisco, CA
Adel Malek, Tufts University School of Medicine, Boston, MA

  9:15 – 11:30 am

SESSION 2: CEREBROVASCULATURE – WHAT IS SMALL AND WHAT IS LARGE IN THE WORLD OF NEUROVASCULAR INTERVENTION?

Location: Metropolitan Ballroom

Chairs: Raul G. Nogueira, UPMC Stroke Institute, USA
Johana Fifi, Mount Sinai Health System, New York, NY

9:15 – 9:35
DISTAL VESSEL OCCLUSION (DVO) & PROXIMAL VESSEL OCCLUSION (PVO) – Imaging Reality
9:15 – 9:25 Presentation by David Liebeskind, UCLA, USA
9:25 – 9:40 Comments by Magdy Selim, Harvard Medical School, Boston, MA
Adnan Qureshi, University of Missouri School of Medicine, Columbia, MO

9:40 – 9:50
INTELLIGENT DATA COLLECTION AND PROCESSING
Presentation by Santiago Ortega-Gutiérrez, University of Iowa, Iowa City, IA

9:50 – 10:10
NET WATER UPTAKE (NWU)
9:50 – 10:00 Presentation by George Harston, Oxford University Hospitals NHS Foundation Trust, UK
10:00 – 10:10 Comments by David Fiorella, Renaissance School of Medicine at Stonybrook University, New York, NY

10:10 – 10:30
WHY DID MeVo TRIAL FAIL
10:10 – 10:20 Presentation by Marc Ribo, Hospital Vall d’Hebron, Spain
10:20 – 10:30 Comments by Fawaz Al- Mufti, Westchester Medical Center Health Network, Valhalla, NY

10:30 – 10:50
FUTURE FOR MeVo TRIALS
10:30 – 10:40 Presentation by Raul Nogueira, University of Pittsburgh School of Medicine, Pittsburgh, PA
10:40 – 10:50 Comments by Jeff Saver, UCLA, USA

10:50 – 11:25
ROUNDTABLE PANEL DISCUSSION

Panelists:

Patrick Noonan, FDA
Leigh Anderson, Acute Stroke Devices Team, FDA
Eytan Raz, NYU Langone Health, New York, NY
Ashutosh Jadhav, Barrow Neurological Institute, Phoenix, AZ
Patrick Brouwer, Johnson&Johnson

 11:40 am –  12:40 pm

AI

Location: Metropolitan Ballroom

Chair: Demetrius Lopes, Advocate Aurora Health, Chicago, IL

11:40 – 11:50
INTRODUCTION TO AI IN NEUROINTERVENTION
Presentation by Thomas Booth, King’s College London, UK

11:50 – 12:04
AUTOMATION IN NEUROINTERVENTION
Presentation by Ansaar Rai, Rockefeller Neurosciences Institute, Morgantown, WV 

12:04 – 12:18
AI IN THE CATH LAB
Presentation by Demetrius Lopes, Advocate Aurora Health, Chicago, IL and Kenichi Kono, Showa University Fujigaoka Hospital, Japan

12:18 – 12:50
ROUNDTABLE PANEL DISCUSSION

Panelists:
Shahram Majidi, Mount Sinai Health System, New York, NY
Mathias Unberath, Johns Hopkins University, MD
Tito Porras, Semaphor Surgical
Max van Appeldorn, Phillips
FDA
NIH

  1:50 pm – 4:10 pm

SESSION 3: COMBINED ACCESS, AI + ROBOTICS INTEGRATION

Location: Metropolitan Ballroom

Chairs: Ricardo Hanel, Baptist Health, Jacksonville, FL

1:50 – 2:10
COMBINED PRESENTATION REGULATORY PATH FOR ROBOTIC NEUROINTERVENTION: SHOULD IT BE DISEASE SPECIFIC?/ FDA PERSPECTIVE: REGULATIONS ON REMOTE THROMBECTOMY

1:50 – 2:10 Presentation by Naira Muradyan, Assistant Director, Acute Stroke Devices Team, FDA
Jaime Raben, Director, Division of Neurosurgical, Neurointerventional, and Neurodiagnostic Devices, FDA

2:10 – 3:10
ROUNDTABLE PANEL DISCUSSION

Panelists:
Carlos Pena, Jacobs Institute, Buffalo, NY
Dileep Yavagal, University of Miami School of Medicine, Miami, FL
Brian Jankowitz, JFK University Medical Center, Edison, NJ
Patrick Noonan, FDA
John Daniel, Stryker
NIH

3:10 – 3:20
ROBOTICS FOR VASCULAR ACCESS
Presentation by Eric Peterson, University of Miami Miller School of Medicine, Miami, FL

3:20 – 3:40
DEBATE ROBOTIC SYSTEMS: DEVICE AGNOSTIC OR DEVICE SPECIFIC
3:20 – 3:30 DEVICE AGNOSTIC
Presentation by Vitor Pereira, University of Toronto and St Michael’s Hospital, Canada
3:30 – 3:40 DEVICE SPECIFIC
Presentation by Aquilla Turk, University of South Carolina, Greenville, SC

3:40 – 4:10
ROUNDTABLE PANEL DISCUSSION

Panelists:
Ramesh Grandhi, University of Utah, Salt Lake City, UT
Satoshi Tateshima, UCLA, Los Angeles, CA
Mark Paul, University of Utah Health, UT
Naira Muradyan, Assistant Director, Acute Stroke Devices Team, FDA
Jaime Raben, Director, Division of Neurosurgical, Neurointerventional, and Neurodiagnostic Devices, FDA
Max van Apeldoorn, Philips
Mike Tracey, Johnson&Johnson
NIH

4:35 – 6:00 pm

SESSION 4: AMBULATORY NEUROINTERVENTIONAL CARE: CLINICAL REALITY OR BUSINESS DISRUPTION?

Location: Metropolitan Ballroom

Chair: Ajay K Wakhloo, Tufts University School of Medicine, Boston, MA

4:35 – 4:40
INTRODUCTION
Ajay K Wakhloo, Tufts University School of Medicine, Boston, MA

4:40 – 5:20
DEBATE: DOES AMBULATORY NEUROINTERVENTIONAL CARE MAKES SENSE?

4:40 – 5:00
YES
Presentation by Elad Levy, University at Buffalo, Buffalo, NY

5:00 – 5:05
Presentation by Aimee DeGaetano, Eastern Virginia Medical School, VA 

5:05 – 5:20
NO
Presentation by Ameer E. Hassan, University of Texas, TX

5:20 – 5:30
AMBULATORY PATIENT CARE: HOSPITAL PERSPECTIVE
Presentation by Elizabeth Baucom, Advocate Health

5:30 – 6:00
ROUNDTABLE PANEL DISCUSSION

Panelists:

David Altschul, Montefiore Medical Center, New York, NY
Charles Matouk, Yale University, USA
Adam Arthur, Medtronic
Aimee DeGaetano, Ambulatory Neurosurgery Center (ANSC)
Chad Evens, Stryker
Ameer E. Hassan, University of Texas, TX
Elad Levy, University at Buffalo, Buffalo, NY
Samuel Shimp, Johnson&Johnson
FDA